Read the current Defeat Diabetes® E-Lerts™ Newsletter

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

 
 
 
     
    
      
       
Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300

Madeira Beach, FL 33708
  

Gene Inhibition Helps to Normalize Type 2 Diabetes

Posted: Tuesday, June 30, 2009

In research that could lead to new approaches for the treatment of Type 2 diabetes, a research team has found that suppressing a liver enzyme that induces glucose production helped diminish the symptoms of the disease — reducing blood glucose concentrations, decreasing rates of glucose production in the liver, and improving insulin sensitivity.

Decreasing expression of the gene, Sirtuin 1, also lowered total cholesterol levels.

Type 2 diabetes is characterized by high blood glucose concentrations and insulin resistance, which play a major factor in causing the disease. In the U.S., rates of Type 2 diabetes have doubled since 1990, and the Centers for Disease Control calls the disease an epidemic. Formerly known as "adult-onset diabetes," the disorder is increasingly diagnosed in children.

The Yale researchers put the rats on a four-week diet of fructose and high-fat meals to create a metabolic condition that mimics Type 2 diabetes. At the same time, they inhibited expression of the Sirtiun 1 gene through injection of an antisense oligonucleotide (short fragments of nucleic acid that inactivate gene expression) specifically targeted to that gene.

First author Derek Erion, a graduate student in cellular and molecular physiology at Yale, said that, "Blood glucose levels in the rats came down close to normal, as did their ability to regulate blood glucose levels with insulin."

The authors believe the falling plasma cholesterol levels that also resulted may be attributed to increased cholesterol uptake and export from the liver, due to suppression of key enzymes involved in cholesterol metabolism.

Senior author Gerald Shulman, MD, said the results indicate that inhibiting Sirtuin 1 in the liver may be an attractive approach for the treatment of Type 2 diabetes. "With this disorder, diet and exercise only get you so far," he said. "Many patients may need drug intervention to avoid suffering the debilitating effects of Type 2 diabetes." Shulman is the George R. Cowgill Professor of Physiological Chemistry, Medicine and Cellular and Molecular Physiology at Yale and a Howard Hughes Medical Institute Investigator.

Source: Diabetes In Control: Yale University (2009, June 19). Gene Inhibition May Help Normalize Type 2 Diabetes. The research appears in the June 15-19 Online Early Edition of the Proceedings of the National Academy of Sciences.

 
 
 
 
 
Join us on Facebook
 
 
 

Send your unopened, unexpired diabetes testing supplies to:

Defeat Diabetes Foundation
150 153rd Ave, Suite 300
Madeira Beach, FL 33708

 

DDF advertisement
 

 Friendly Banner
 


Friendly Banner
 
 
 
Analyze nutrition content by portion
DDF advertisement